Medical Device Network on MSN
Roche launches Axelios 1 sequencing platform
The launch was supported by collaborations with institutions such as the Hartwig Medical Foundation and Broad Clinical Labs.
When Roche previewed the Axelios technology in February, a Jefferies analyst called the next-generation sequencing platform the “greatest credible competitive threat in years.” ...
AXELIOS 1 delivers a unique combination of accuracy, speed, scalability and cost efficiency, giving laboratories of all sizes ...
Roche may have failed to buy out Illumina back in 2012, but now it’s trying to take up some of the gene sequencing specialist ...
Roche debuts Axelios, a gene sequencer targeting academic and research facilities, to compete with Illumina's dominance in ...
Ultima Genomics, Inc., a developer of ultra-high-throughput sequencing systems, continues its mission to enable sequencing at scale with the unveiling of the UG200 Series and next generation Solaris 2 ...
The US Food and Drug Administration (FDA) has released draft guidance on how sponsors can utilize next-generation sequencing (NGS) methods in nonclinical studies to assess the safety risks associated ...
Roche Holding AG is looking to take a share of Illumina Inc.’s dominance in the gene sequencing market with the launch of Axelios 1, its next-generation sequencing (NGS) platform designed for accuracy ...
Roche launches AXELIOS 1, a transformative next-generation sequencing platform: Basel Tuesday, June 30, 2026, 10:00 Hrs [IST] Roche, a healthcare company, announced the launch of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results